News Merck takes a back seat on CAR-T, handing assets to Intrexon Merck KGaA wants to get bigger in immuno-oncology, but from now on it won’t be taking a direct role in the drive to develop new CAR-T therapies.
News Samsung builds digital health credentials with Xealth buy Samsung has reached a deal to buy Xealth, a US company set up to help healthcare professionals prescribe digital health technologies.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face